Covaxin trials

Covaxin Shows 78 Percent Efficacy In Phase 3 Analysis; Results To Be Out Officially In June

Officials say Bharat Biotech's vaccine has shown efficacy of 78% in preventing symptomatic COVID-19 in the final phase 3 analysis